Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Karoui

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 19, 2019
Thirty-day mortality after emergency surgery for obstructing colon cancer: survey and dedicated score from the French Surgical AssociationG Manceau, D Mege, V Bridoux, et al.
Techniques in Coloproctology|January 16, 2020
Elective surgery for tumours of the splenic flexure: a French inter-group (AFC, SFCD, FRENCH, GRECCAR) surveyG Manceau, S Benoist, Y Panis, et al.
Pathologie-Biologie|August 3, 2010
Evaluation of serum VEGF levels in untreated erythrocytosis patientsC Maktouf, A Bounemra, S Mahjoub, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 18, 2014
Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experienceL de Mestier, C Neuzillet, A Pozet, et al.
Journal of Visceral Surgery|April 6, 2019
Surgical management of obstructive left colon cancer at a national level: Results of a multicentre study of the French Surgical Association in 1500 patientsD Mege, G Manceau, V Bridoux, et al.
Gut|October 30, 2007
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomasS Le Gouvello, S Bastuji-Garin, N Aloulou, et al.
ESMO Open|August 1, 2025
Neoadjuvant immunotherapy for nonmetastatic dMMR/MSI colon cancer: a real-world retrospective AGEO studyC Lemaire, A Boileve, G Manceau, et al.
ESMO Open|December 22, 2022
FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailtyJ R Platt, O M Todd, P Hall, et al.
Annals of Surgical Oncology|June 19, 2019
Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 TrialM Bruzzi, E Auclin, R Lo Dico, et al.
Annals of Surgery|July 30, 2019
Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22)M Karoui, A Rullier, G Piessen, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 19, 2019
Thirty-day mortality after emergency surgery for obstructing colon cancer: survey and dedicated score from the French Surgical AssociationG Manceau, D Mege, V Bridoux, et al.
Techniques in Coloproctology|January 16, 2020
Elective surgery for tumours of the splenic flexure: a French inter-group (AFC, SFCD, FRENCH, GRECCAR) surveyG Manceau, S Benoist, Y Panis, et al.
Pathologie-Biologie|August 3, 2010
Evaluation of serum VEGF levels in untreated erythrocytosis patientsC Maktouf, A Bounemra, S Mahjoub, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 18, 2014
Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experienceL de Mestier, C Neuzillet, A Pozet, et al.
Journal of Visceral Surgery|April 6, 2019
Surgical management of obstructive left colon cancer at a national level: Results of a multicentre study of the French Surgical Association in 1500 patientsD Mege, G Manceau, V Bridoux, et al.
Gut|October 30, 2007
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomasS Le Gouvello, S Bastuji-Garin, N Aloulou, et al.
ESMO Open|August 1, 2025
Neoadjuvant immunotherapy for nonmetastatic dMMR/MSI colon cancer: a real-world retrospective AGEO studyC Lemaire, A Boileve, G Manceau, et al.
ESMO Open|December 22, 2022
FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailtyJ R Platt, O M Todd, P Hall, et al.
Annals of Surgical Oncology|June 19, 2019
Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 TrialM Bruzzi, E Auclin, R Lo Dico, et al.
Annals of Surgery|July 30, 2019
Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22)M Karoui, A Rullier, G Piessen, et al.
Pageof 4